Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,919 | -89,380 | -60,427 | -53,492 | -25,474 |
| Depreciation Amortization | 1,891 | 7,043 | 5,190 | 3,374 | 1,671 |
| Accounts payable and accrued liabilities | -1,426 | -856 | -2,502 | -3,651 | -1,916 |
| Other Working Capital | -4,971 | -10,551 | -12,831 | -9,970 | -6,128 |
| Other Operating Activity | 5,662 | 18,221 | 15,655 | 12,434 | 6,198 |
| Operating Cash Flow | $-26,763 | $-75,523 | $-54,915 | $-51,305 | $-25,649 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -953 | -4,676 | -3,991 | -3,527 | -2,247 |
| Purchase Of Investment | -5,270 | -97,934 | -75,728 | -43,795 | -22,513 |
| Sale Of Investment | 44,257 | 158,312 | 126,125 | 77,807 | 37,751 |
| Investing Cash Flow | $38,034 | $55,702 | $46,406 | $30,485 | $12,991 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32 | 116 | 108 | 36 | 19 |
| Common Stock Repurchased | N/A | -33 | N/A | N/A | N/A |
| Other Financing Activity | -197 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-165 | $83 | $108 | $36 | $19 |
| Beginning Cash Position | 37,601 | 55,939 | 55,939 | 55,939 | 55,939 |
| End Cash Position | 48,707 | 36,201 | 47,538 | 35,155 | 43,300 |
| Net Cash Flow | $11,106 | $-19,738 | $-8,401 | $-20,784 | $-12,639 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,763 | -75,523 | -54,915 | -51,305 | -25,649 |
| Capital Expenditure | -953 | -4,676 | -3,991 | -3,527 | -2,247 |
| Free Cash Flow | -27,716 | -80,199 | -58,906 | -54,832 | -27,896 |